Eli Lilly and Company (NYSE: LLY) is launching an open innovation challenge to encourage individuals and teams across the U.S. to identify and submit pioneering digital health solutions aimed at transforming inflammatory bowel disease (IBD) care. The challenge, “Transforming IBD Care: Better disease monitoring, management, and care for people with inflammatory bowel disease” focuses on innovation in IBD monitoring, condition management or care enhancements.
{iframe}https://hitconsultant.net/2019/08/14/lilly-launches-innovation-challenge-to-transform-ibd-care-through-digital-health/#.XVrJG5NKjxs{/iframe}